1. Home
  2. ONTF vs ORGO Comparison

ONTF vs ORGO Comparison

Compare ONTF & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON24 Inc.

ONTF

ON24 Inc.

HOLD

Current Price

$8.11

Market Cap

347.2M

Sector

Technology

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.35

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONTF
ORGO
Founded
1998
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
347.2M
348.6M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
ONTF
ORGO
Price
$8.11
$2.35
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$8.10
$8.50
AVG Volume (30 Days)
986.7K
1.3M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
32.67
1600.00
EPS
N/A
N/A
Revenue
$139,312,000.00
$564,169,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.51
$26.27
P/E Ratio
N/A
$16.73
Revenue Growth
N/A
17.04
52 Week Low
$4.70
$2.21
52 Week High
$8.11
$7.08

Technical Indicators

Market Signals
Indicator
ONTF
ORGO
Relative Strength Index (RSI) 67.87 43.03
Support Level $7.84 $2.26
Resistance Level N/A $2.60
Average True Range (ATR) 0.02 0.16
MACD -0.01 0.02
Stochastic Oscillator 88.89 46.38

Price Performance

Historical Comparison
ONTF
ORGO

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others. Geographically, the company derives maximum revenue from United States, and also has its presence in EMEA and Other Countries.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: